Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mankodi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2000
Posttraumatic akinetic-rigid syndrome resembling Parkinson's disease: a report on three patientsM Bhatt, J Desai, A Mankodi, et al.
Brain : a Journal of Neurology|January 5, 1999
A clinicogenetic analysis of six Indian spinocerebellar ataxia (SCA2) pedigrees. The significance of slow saccades in diagnosisN Wadia, J Pang, J Desai, et al.
British Journal of Clinical Pharmacology|November 1, 1983
Phase 1 tolerability and antiamoebic activity studies with 1-methylsulphonyl-3-(1-methyl-5-nitro-2-imidazolyl)-2-imidazolidinone (Go.10213): a new antiprotozoal agentA B Vaidya, D K Ray, N A Mankodi, et al.
British Journal of Clinical Pharmacology|August 1, 1977
Phase 1 tolerability and searching dose studies with 4-isothiocyanato-4'-nitrodiphenylamine (C.9333-Go/CGP 4540), a new anthelminticA B Vaidya, H G Sen, N A Mankodi, et al.
Science (New York, N.Y.)|September 8, 2000
Myotonic dystrophy in transgenic mice expressing an expanded CUG repeatA Mankodi, E Logigian, L Callahan, et al.
The American Journal of Tropical Medicine and Hygiene|July 1, 1977
Clinical trials of a new anthelmintic, 4-isothiocyanato-4'-nitrodiphenylamine (C.9333-Go/CGP 4540), for the cure of hookworm infectionJ C Doshi, A B Vaidya, H G Sen, et al.
Human Molecular Genetics|October 9, 2001
Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2A Mankodi, C R Urbinati, Q P Yuan, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2000
Posttraumatic akinetic-rigid syndrome resembling Parkinson's disease: a report on three patientsM Bhatt, J Desai, A Mankodi, et al.
Brain : a Journal of Neurology|January 5, 1999
A clinicogenetic analysis of six Indian spinocerebellar ataxia (SCA2) pedigrees. The significance of slow saccades in diagnosisN Wadia, J Pang, J Desai, et al.
British Journal of Clinical Pharmacology|November 1, 1983
Phase 1 tolerability and antiamoebic activity studies with 1-methylsulphonyl-3-(1-methyl-5-nitro-2-imidazolyl)-2-imidazolidinone (Go.10213): a new antiprotozoal agentA B Vaidya, D K Ray, N A Mankodi, et al.
British Journal of Clinical Pharmacology|August 1, 1977
Phase 1 tolerability and searching dose studies with 4-isothiocyanato-4'-nitrodiphenylamine (C.9333-Go/CGP 4540), a new anthelminticA B Vaidya, H G Sen, N A Mankodi, et al.
Science (New York, N.Y.)|September 8, 2000
Myotonic dystrophy in transgenic mice expressing an expanded CUG repeatA Mankodi, E Logigian, L Callahan, et al.
The American Journal of Tropical Medicine and Hygiene|July 1, 1977
Clinical trials of a new anthelmintic, 4-isothiocyanato-4'-nitrodiphenylamine (C.9333-Go/CGP 4540), for the cure of hookworm infectionJ C Doshi, A B Vaidya, H G Sen, et al.
Human Molecular Genetics|October 9, 2001
Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2A Mankodi, C R Urbinati, Q P Yuan, et al.
Pageof 1